Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Allena reports phase IIa data on ALLN-177 for the treatment of hyperoxaluria

March 19, 2015

Astellas submits supplemental NDA for Kiklin in Japan

March 19, 2015

Sanofi presents new anti-PAI-1 MAbs

March 6, 2015

Boston Scientific to acquire American Medical Systems' urology portfolio

March 5, 2015

EMA's CHMP backs approval of Jinarc for rare kidney disease

March 2, 2015

InSys in-licenses novel therapy for chronic pelvic pain syndrome

Feb. 26, 2015

Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists

Feb. 16, 2015

ViveBio signs licensing agreement with Renovar for urine-based biomarkers for kidney disease

Feb. 13, 2015

Aurinia plans pilot biomarker study of voclosporin in lupus nephritis

Feb. 11, 2015

Tenapanor achieves primary endpoint in phase IIb hyperphosphatemia trial

Feb. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...